Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.

Irfan CicinElizabeth R PlimackHoward GurneyRaya LeibowitzBoris Y AlekseevFrancis X ParnisAvivit PeerAndrea NecchiJoaquim BellmuntHiroyuki NishiyamaJason ClarkMihaela MunteanuRitesh KatariaCalvin JiaThomas PowlesCora N Sternberg

Published in: BMC cancer (2024)

ClinicalTrials.gov, NCT03374488. Registered 12/15/2017.

Keyphrases

phase iii
open label
double blind
phase ii
placebo controlled
clinical trial
advanced non small cell lung cancer
magnetic resonance
study protocol
randomized controlled trial
diffusion weighted imaging